• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CTE 3.53% 82.0¢

CRYOSITE LIMITED

Cryosite Limited is engaged in providing outsourced clinical trials depot services. The... Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CTE 26/04/24 0 150
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  150 
CTE 26/04/24 0 147
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  147 
CTE 26/04/24 0 113
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  113 
CTE 26/04/24 0 141
26/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  141 
CTE 23/02/24 0 224
23/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  224 
CTE 23/02/24 0 123
23/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  123 
CTE 22/02/24 0 218
22/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  218 

See All Discussions arrow Created with Sketch.

Timeline

Change in substantial holding
26 Apr 11:59
 
Change of Director's Interest Notice - Mark Kerr
26 Apr 11:56
 
Change in substantial holding
26 Apr 11:52
 
Change of Director's Interest Notice - Andrew Kroger
26 Apr 11:50
 
Initial Director's Interest Notice - Andrew Kerr
23 Feb 11:19
 
Final Director's Interest Notice - John Hogg
23 Feb 11:16
 
View More arrow Created with Sketch.
(20min delay)
Last
82.0¢
Change
-0.030(3.53%)
Mkt cap ! $40.02M
Open High Low Value Volume
85.0¢ 86.5¢ 82.0¢ $878.6K 1.033M

Buyers (Bids)

No. Vol. Price($)
1 551 82.0¢
 

Sellers (Offers)

Price($) Vol. No.
85.0¢ 15324 1
View Market Depth
Last trade - 15.59pm 03/05/2024 (20 minute delay) ?
Last
85.0¢
  Change
-0.030 ( 0.00 %)
Open High Low Volume
85.0¢ 85.0¢ 85.0¢ 619
Last updated 11.17am 03/05/2024 ?
CTE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.